Internal Medicine, Pulmonary Disease · Trujillo Alto, PR
NPI
1104077213
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Hc 645, Box 5131
Trujillo Alto, PR, 00976
Phone (787) 241-3363
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,330
31 services
Medicare patients, 2024
18
Average age 77
Drug cost, 2024
$5.3M
3,747 prescriptions
Company payments, 2025
$1,579
From 16 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jesse R Aleman-Ortiz prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 831 prescriptions and refills. In total Jesse R Aleman-Ortiz wrote 3,747 Medicare prescriptions that cost $5.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 831 | 846 | 182 | $35K |
| Breo Ellipta Fluticasone/Vilanterol | 503 | 523 | 103 | $213K |
| Montelukast Sodium Generic | 345 | 433 | 87 | $3,200 |
| Fluticasone Propionate Generic | 241 | 282 | 61 | $4,841 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 221 | 237 | 34 | $153K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 163 | 166 | 36 | $10K |
| Adempas Riociguat | 139 | 139 | 16 | $1.9M |
| Opsumit Macitentan | 135 | 135 | 15 | $1.7M |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 127 | 127 | 20 | $63K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 93 | 95 | 20 | $25K |
| Famotidine Generic | 77 | 85 | 28 | $453 |
| Symbicort Budesonide/Formoterol Fumarate | 72 | 72 | 27 | $17K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 64 | 64 | Under 11 | $30K |
| Ofev Nintedanib Esylate | 61 | 61 | Under 11 | $780K |
| Sildenafil Citrate Generic | 59 | 67 | 11 | $1,491 |
Brand drugs: 2,283 claims; generic drugs: 1,464 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesse R Aleman-Ortiz $1,579 ($1,579 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $496.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $496 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $182 |
| Merck Sharp & Dohme LLC MRK | 6 | $176 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $106 |
| Genzyme Corporation SNY | 4 | $93.58 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 2 | $45.1 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $44.86 |
| Viatris Specialty LLC | 2 | $41.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.